HIV, STI, Viral Hepatitis, and Harm Reduction Digest
August 16, 2023
NACCHO’s New Refugee, Immigrant, and Migrant Program Website
We are delighted to unveil the brand-new “RIM Website” – a dedicated online space tailored to the unique needs of Refugee, Immigrant, and Migrant communities.
Discover the RIM Website: Refugee, Immigrant, and Migrant Programs - NACCHO
The website highlights NACCHO’s unwavering commitment to delivering pertinent and timely resources for LHDs and CBOs involved in the health and wellbeing of RIM communities. By visiting the RIM website, you will have access to an extensive array of resources, tools, and insights designed to support efforts in addressing the challenges faced by Refugee, Immigrant, and Migrant populations.
Key Highlights of the RIM Website:
Tailored Resources: Explore a carefully curated selection of resources specifically geared towards promoting the health and well-being of Refugee, Immigrant, and Migrant communities.
Interactive Learning: Explore webinars and workshops that provide practical skills and knowledge aimed at improving health outcomes and fostering inclusivity within Refugee, Immigrant, and Migrant populations.
Data Insights: Stay informed with the latest Emerging Promising Practices related to the health and challenges of RIM communities.
Exploring Program Sites: Delve into our varied portfolio of program sites and explore their dedicated efforts to address the distinct needs of Refugee, Immigrant, and Migrant communities across different jurisdictions throughout the nation.
Site Spotlights: Immerse yourself in illuminating site spotlights that showcase our program sites and their multifaceted approach to enhancing well-being within Refugee, Immigrant, and Migrant populations. These spotlights offer a firsthand look into innovative strategies and collaborative triumphs.
Conferences: Dive into a wealth of knowledge by exploring the diverse conferences that the RIM Program has attended. Learn more about enlightening discussions, transformative workshops, and informative panels.
As we continually update and expand our website, we highly value your feedback and suggestions to ensure that it remains an invaluable resource center for all matters pertaining to Refugee, Immigrant, and Migrant communities.
NACCHO Seeks Training Consultant to Support STI Treatment Guidelines Activities
NACCHO is working with the Center for Disease Control and Prevention’s (CDC’s) Division of STD Prevention (DSTDP) to support the updating of its’ STI Treatment Guideline process. The STI treatment guidelines committee is searching for an academic expert or group to train the committee in evidence-based guidelines development process including systematic reviews and best associated software programs, evidence appraisal, and use of evidence-to-decision tables for ~25-30 physicians at CDC. The format of the training should include some in-person training in Atlanta over ~2-3 days and some virtual components. Deadline for applications is 8/23.
RFA: Two New Immunization Funding Opportunities
NACCHO, with support from the Centers for Disease Control and Prevention (CDC), is pleased to provide two new funding opportunities. The Strengthening Vaccine Confidence and Uptake among Adolescents and their Families through Community Partnerships project and The Improving Vaccine Access, Education, and Outreach Through Faith-Based Partnerships project are both now accepting applications.
HIV, STI, & Hepatitis Resources and News
NASTAD Statement: HIV Cluster and Outbreak Detection and Response (CDR) & Molecular HIV Surveillance (MHS)
This document serves as a resource for both NASTAD and its members for communications, community engagement, and advocacy purposes to reflect common concerns, issues, and priorities held by health departments around the implementation of CDR and MHS strategies. Specific areas of focus in the statement include community engagement, the protection of public health data, assessing and addressing HIV criminalization, supporting flexible implementation of CDR programs, and program utility and evaluation.
CDC DHP Resource: Success Stories: EHE in Action
The CDC Division of HIV Prevention (DHP) published two new success stories:
- NASTAD: Expanding TelePrEP in EHE Jurisdictions Through Online Learning and Collaboration
- Baltimore City Health Department: Dismantling HIV and STI Testing Barriers in Baltimore City, MD with Self- and Mail-In Tests
Injectable Syphilis Treatment Delivery: Considerations for STD Programs
STD public health programs stand on the frontlines in the fight against the syphilis epidemic, as rates continue to increase, providing partner services, surveillance, case management, and appropriate treatment. State and local STD programs are now relying on primary health care providers to diagnose and treat syphilis more than ever. Learn more about Injectable Syphilis Treatment Delivery (ISTD) programs & best practices.
Hello HumpDaze: DIS Bi-weekly Newsletter from NCSD
HumpDaze is a bi-weekly newsletter for Disease Intervention Specialists (DIS) produced by the National Coalition of STD Directors (NCSD). Sliding into your inbox every other Wednesday, HumpDaze is written by and for DIS to connect, cut it up, and have a few laughs in all the chaos. Our first issue went out last week and we’ve enjoyed hearing from y’all! If you haven’t signed up yet, subscribe here so you don’t miss the next issue.
Learn More About NCSD’s DIS Work.
News to Note
NIH taps Jeanne Marrazzo to succeed Fauci as infectious-disease chief – The Washington Post
The potential benefits and risks of fighting STIs with doxycycline – PBS
Upcoming Opportunities
Health Department Activities for the Prevention of Congenital Syphilis & Perinatal HIV
August 30, 2023- 2 PM EST
Join NACCHO, NASTAD, and NCSD on August 30, 2023 as we review NACCHO’s perinatal HIV and congenital syphilis compendium and highlight programs across the country implementing policies and practices that interrupt congenital syphilis and perinatal HIV transmission.
Register Here.
September 26, 2023- 3:30 PM EST
This webinar reviews the current recommendations by the Centers for Disease Control and Prevention (CDC) for the use of doxy-PEP. Topics will include the criteria to determine appropriate candidates for doxy-PEP therapy, strategies for effective doxy-PEP administration, and questions that remain to be answered in future studies on doxy-PEP in patients with HIV.
